Department of Nephrology Transplant Center Institute for Clinical and Experimental Medicine Prague Czechia

Department of Nephrology University Hospital Regensburg Regensburg Germany

Division of Nephrology and Dialysis Department of Medicine 3 Medical University of Vienna Vienna Austria

Division of Nephrology Medical University of Graz Graz Austria

Editorial on the Research Topic Advances in the diagnosis and treatment in kidney transplantation PubMed

Zobrazit více v PubMed

Vanholder R, Domínguez-Gil B, Busic M, Cortez-Pinto H, Craig JC, Jager KJ, et al. . Organ donation and transplantation: a multi-stakeholder call to action. Nat Rev Nephrol. (2021) 17:554–68. 10.1038/s41581-021-00425-3 PubMed DOI PMC

Pippias M, Stel VS, Arnol M, Bemelman F, Berger SP, Ponikvar JBB, et al. . Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry. Nephrol Dial Transplant. (2021) 37:175–86. 10.1093/ndt/gfab156 PubMed DOI PMC

Moers C, Stel VS, Arnol M, Bemelman F, Berger SP, Ponikvar JBB, et al. . Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. (2009) 360:7–19. 10.1056/NEJMoa0802289 PubMed DOI

Elliott TR, Nicholson ML, Hosgood SA. Normothermic kidney perfusion: an overview of protocols and strategies. Am J Transplant. (2021) 21:1382–90. 10.1111/ajt.16307 PubMed DOI

Halloran PF, Famulski KS, Reeve J. Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol. (2016) 12:534–48. 10.1038/nrneph.2016.85 PubMed DOI

Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Bernnan D, et al. . Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study. Am J Transplant. (2017) 17:2851–62. 10.1111/ajt.14329 PubMed DOI

Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, et al. . Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. (2017) 28:2221–32. 10.1681/ASN.2016091034 PubMed DOI PMC

Banas M, Neumann S, Eiglsperger J, Schiffer E, Putz FJ, Reichell-Wurm S, et al. . Identification of a urine metabolite constellation characteristic for kidney allograft rejection. Metabolomics. (2018) 14:116. 10.1007/s11306-018-1419-8 PubMed DOI PMC

Bohmig GA, Eskandary F, Doberer K, Halloran PF. The therapeutic challenge of late antibody-mediated kidney allograft rejection. Transpl Int. (2019) 32:775–88. 10.1111/tri.13436 PubMed DOI PMC

Montgomery RA, Loupy A, Segev DL. Antibody-mediated rejection: new approaches in prevention and management. Am J Transplant. (2018) 18(Suppl.3):3–17. 10.1111/ajt.14584 PubMed DOI

Van Loon E, Bernards J, Van Craenenbroeck AH, Naesens M. The causes of kidney allograft failure: more than alloimmunity. A viewpoint article. Transplantation. (2020) 104:e46–56. 10.1097/TP.0000000000003012 PubMed DOI

Leenders NHJ, Bos C, Hoekstra T, Schurgers LJ, Vervloet MG, Hoenderop JGJ. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease. Nephrol Dial Transplant. (2022) 37:1049–58. 10.1093/ndt/gfac026 PubMed DOI PMC

Del Gobbo LC, Imamura F, Wu JHY, de Oliveira Otto MC, Chiruve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. (2013) 98:160–73. 10.3945/ajcn.112.053132 PubMed DOI PMC

Hod T, Isakov O, Patibandla BK, Christopher KB, Hershkoviz R, Schwartz IF, et al. . Posttransplantation hypomagnesemia as a predictor of better graft function after transplantation. Kidney Blood Press Res. (2020) 45:982–95. 10.1159/000510797 PubMed DOI

Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. . Dapagliflozin in patients with chronic kidney disease. N Engl J Med. (2020) 383:1436–46. 10.1056/NEJMoa2024816 PubMed DOI

Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, et al. . Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus. Diabetes Care. (2019) 42:1067–74. 10.2337/dc19-0093 PubMed DOI

Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, et al. . Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety. Am J Transplant. (2019) 19:907–19. 10.1111/ajt.15223 PubMed DOI PMC

Akalin E, Azzi A, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. . Covid-19 and kidney transplantation. N Engl J Med. (2020) 382:2475–7. 10.1056/NEJMc2011117 PubMed DOI PMC